UPDATE 3-MannKind's inhaled insulin verdict delayed | Reuters

Links shared publicly online about this topic.

  • 620
    total visits

UPDATE 3-MannKind's inhaled insulin verdict delayed | Reuters

reuters.com

* Says FDA will not be able to complete review by Dec. 29 * Says FDA requires about 4 more weeks to complete review * Shares rise as much as 11.5 percent (Adds analyst comment, updates share price)

View full resource at reuters.com

Tags: Diabetes, Insulin, FDA

  • Share

Most Recently Shared on December 29, 2010 at 2:55 pm By:

ReutersDChealth Susan Heavey

Looks like another 4 wks until #FDA rules on $MNKD inhaled insulin: http://link.reuters.com/vyv93r #diabetes

1 year ago...

Advertisement